Sterility testing of apheresis hematopoietic progenitor cell products using an automated blood culture system

Transfusion

Volumn 53, Issue 11, 2013, Pages 2659-2666

  Liu, Chang ^a   Weber, Carol ^a   Sempek, Diane S ^a   Grossman, Brenda J ^a   Burnham, Carey Ann D ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

APHERESIS; ARTICLE; AUTOMATED BLOOD CULTURE SYSTEM; AUTOMATION; BACILLUS CEREUS; BACTERIAL GROWTH; BACTEROIDES FRAGILIS; BLOOD CULTURE; CANDIDA ALBICANS; CLOSTRIDIUM PERFRINGENS; COLONY FORMING UNIT; FUNGUS GROWTH; FUSOBACTERIUM NECROPHORUM; GENE AMPLIFICATION; HEMATOPOIETIC STEM CELL; LIMIT OF DETECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVOTELLA LOESCHEII; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MITIS; TURNAROUND TIME;

BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; BLOOD COMPONENT REMOVAL; HEMATOPOIETIC STEM CELLS; HUMANS; POLYMERASE CHAIN REACTION; PREVOTELLA; REPRODUCIBILITY OF RESULTS; RNA, RIBOSOMAL, 16S; STERILIZATION;

EID: 84887816084     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12115     Document Type: Article

References (36)

1. American Association of Blood Banks. Standards for cellular therapy product services. 4th ed. Bethesda (MD): American Association of Blood Banks; 2009.
2. American Association of Blood Banks. Standards for cellular therapy product services. 5th ed. Bethesda (MD): American Association of Blood Banks; 2011.
3. American Association of Blood Banks. Summary of significant changes to the standards for cellular therapy product services. 4th ed. American Association of Blood Banks; 2010. [cited 2012 Nov 21]. Available from: URL: http://www.aabb.org/sa/standards/Documents/sigchngctstds4ed.pdf
4. Brook I,. The role of anaerobic bacteria in bacteremia. Anaerobe 2010; 16: 183-189.
5. Webb IJ, Coral FS, Andersen JW, Elias AD, Finberg RW, Nadler LM, Ritz J, Anderson KC,. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996; 36: 782-788.
6. Attarian H, Bensinger WI, Buckner CD, McDonald DL, Rowley SD,. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996; 17: 699-702.
7. Nasser RM, Hajjar I, Sandhaus LM, Hall GS, Avery RK, Bolwell BJ, Longworth DL, Adal KA,. Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review. Clin Infect Dis 1998; 27: 886-888.
8. Padley DJ, Dietz AB, Gastineau DA,. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products. Transfusion 2007; 47: 636-643.
9. Schwella N, Rick O, Heuft HG, Miksits K, Zimmermann R, Zingsem J, Eckstein R, Huhn D,. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course. Vox Sang 1998; 74: 88-94.
10. Cohen A, Tepperberg M, Waters-Pick B, Coniglio D, Perfect J, Peters WP, Gilbert C, Morgan C, Vredenburgh JJ,. The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy. J Hematother 1996; 5: 289-294.
11. Kelly M, Roy DC, Labbe AC, Laverdiere M,. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria? Bone Marrow Transplant 2006; 38: 183-188.
12. Food and Drug Administration. Guidance for industry: validation of growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products. 2008. [cited 2012 Nov 21]. Available from: URL: http://www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ ucm078696.pdf
13. Ansel HC, Norred WP, Roth IL,. Antimicrobial activity of dimethyl sulfoxide against Escherichia coli, Pseudomonas aeruginosa, and Bacillus megaterium. J Pharm Sci 1969; 58: 836-839.
14. Basch H, Gadebusch HH,. In vitro antimicrobial activity of dimethylsulfoxide. Appl Microbiol 1968; 16: 1953-1954.
15. Patel P, Garson JA, Tettmar KI, Ancliff S, McDonald C, Pitt T, Coelho J, Tedder RS,. Development of an ethidium monoazide-enhanced internally controlled universal 16S rDNA real-time polymerase chain reaction assay for detection of bacterial contamination in platelet concentrates. Transfusion 2012; 52: 1423-1432.
16. Mohammadi T, Reesink HW, Vandenbroucke-Grauls CM, Savelkoul PH,. Optimization of real-time PCR assay for rapid and sensitive detection of eubacterial 16S ribosomal DNA in platelet concentrates. J Clin Microbiol 2003; 41: 4796-4798.
17. Mohammadi T, Pietersz RN, Vandenbroucke-Grauls CM, Savelkoul PH, Reesink HW,. Detection of bacteria in platelet concentrates: comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing. Transfusion 2005; 45: 731-736.
18. Ziga ED, Druley T, Burnham CA,. Herbaspirillum species bacteremia in a pediatric oncology patient. J Clin Microbiol 2010; 48: 4320-4321.
19. Watson ME, Jr, Estabrook MM, Burnham CA,. Catheter-associated Nocardia higoensis bacteremia in a child with acute lymphocytic leukemia. J Clin Microbiol 2011; 49: 469-471.
20. Han Z, Burnham CA, Clohisy J, Babcock H,. Mycoplasma pneumoniae periprosthetic joint infection identified by 16S ribosomal RNA gene amplification and sequencing: a case report. J Bone Joint Surg Am 2011; 93: e103.
21. Clinical Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline, MM18-A. Wayne (PA): Clinical Laboratory Standards Institute; 2008.
22. Foundation for the Accreditation of Cellular Therapy (FACT). International standards for cellular therapy product collection, processing, and administration accreditation manual. 5th ed. Omaha (NE): FACT; 2012.
23. Food and Drug Administration. General biological products standards-sterility, 21 CFR Sect. 610.12., 2011.
24. Klein MA, Kadidlo D, McCullough J, McKenna DH, Burns LJ,. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae. Biol Blood Marrow Transplant 2006; 12: 1142-1149.
25. Clark P, Trickett A, Stark D, Vowels M,. Factors affecting microbial contamination rate of cord blood collected for transplantation. Transfusion 2012; 52: 1770-1777.
26. Ortega M, Rovira M, Almela M, Marco F, de la, Bellacasa JP, Martínez JA, Carreras E, Mensa J,. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005; 84: 40-46.
27. Chizuka A, Kami M, Kanda Y, Murashige N, Kishi Y, Hamaki T, Kim SW, Hori A, Kojima R, Mori SI, Tanosaki R, Gomi H, Takaue Y,. Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 577-582.
28. Candoni A, Fili C, Trevisan R, Silvestri F, Fanin R,. Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphoma. Clin Microbiol Infect 2003; 9: 1112-1115.
29. Lark RL, McNeil SA, VanderHyde K, Noorani Z, Uberti J, Chenoweth C,. Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 2001; 33: 338-343.
30. Khuu HM, Patel N, Carter CS, Murray PR, Read EJ,. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method. Transfusion 2006; 46: 2071-2082.
31. Mastronardi C, Yang L, Halpenny M, Toye B, Ramírez-Arcos S,. Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services. Transfusion 2012; 52: 1778-1784.
32. Mirrett S, Hanson KE, Reller LB,. Controlled clinical comparison of VersaTREK and BacT/ALERT blood culture systems. J Clin Microbiol 2007; 45: 299-302.
33. Nanua S, Weber C, Isgriggs L, Dunne WM, Jr,. Performance evaluation of the VersaTREK blood culture system for quality control testing of platelet units. J Clin Microbiol 2009; 47: 817-818.
34. Petershofen EK, Fislage R, Faber R, Schmidt H, Roth WK, Seifried E,. Detection of nucleic acid sequences from bacterial species with molecular genetic methods. Transfus Sci 2000; 23: 21-27.
35. Rood IG, Koppelman MH, Pettersson A, Savelkoul PH,. Development of an internally controlled PCR assay for broad range detection of bacteria in platelet concentrates. J Microbiol Methods 2008; 75: 64-69.
36. American Association of Blood Banks. Standards for blood banks and transfusion services. 27th ed. Bethesda (MD): American Association of Blood Banks; 2011.